Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

The Heptagon Future Trends Fund's investment thesis on Galderma Group AG ($GALD.SW) — Q1 2026 | Buyside Digest

All Pitches

View Letter Analysis

$GALD.SWNASDAQGalderma Group AG

BULL

The Heptagon Future Trends Fund—GALD.SW

Fund Letter

Q1 2026

Published March 31, 2026

View Fund Profile

$170.95USD

+7.8% vs last month

$156.50Pitched

+9.2% since pitch

Market Cap$41.6B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Galderma operates as a leading pure-play dermatology giant at the intersection of beauty and healthcare, consistently outgrowing its broader market. Guided by targets...

— The Heptagon Future Trends Fund

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $GALD.SW, and what else The Heptagon Future Trends Fund is buying.

Other pitches on $GALD.SW

Other investors who've written on Galderma Group AG

No other institutional pitches found for this ticker yet.

View all $GALD.SW pitches →